Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
21.5M
-
Shares change
-
+270K
-
Total reported value, excl. options
-
$80.7M
-
Value change
-
+$1.72M
-
Number of buys
-
18
-
Number of sells
-
-28
-
Price
-
$3.75
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q3 2017
64 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q3 2017.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.5M shares
of 44.7M outstanding shares and own 48.2% of the company stock.
Largest 10 shareholders include First Light Asset Management, LLC (4.12M shares), HEARTLAND ADVISORS INC (2M shares), DIMENSIONAL FUND ADVISORS LP (1.74M shares), VANGUARD GROUP INC (1.57M shares), ROYCE & ASSOCIATES LP (1.56M shares), BlackRock Inc. (1.54M shares), Glacier Peak Capital LLC (1.33M shares), BRIDGEWAY CAPITAL MANAGEMENT INC (786K shares), SEGALL BRYANT & HAMILL, LLC (762K shares), and Foundry Partners, LLC (755K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.